SCHEMBL21908488

SCHEMBL21908488

CCC(CCCCCCOC(=O)C1CC(C)(C)N(C)C1(C)C)OC(=O)C1CC(C)(C)N(C)C1(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21908486 1.00 EPHX2 (0.31) EPHX2
SCHEMBL21908485 1.00 EPHX2 (0.31) EPHX2
SCHEMBL21908487 0.99 EPHX2 (0.32) EPHX2
SCHEMBL21908484 0.95 EPHX2 (0.32) EPHX2
SCHEMBL21103041 0.91
SCHEMBL21103044 0.91
SCHEMBL21103042 0.91
SCHEMBL21908483 0.90
SCHEMBL21908625 0.89 SLC18A2 (0.33) EPHX2
SCHEMBL21908628 0.89 SLC18A2 (0.33) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633590-B2 Liquid crystal composition and liquid crystal display device including the same DIC CORPORATION (JP) 2020-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10633590-B2 Liquid crystal composition and liquid crystal display device including the same LASP1, UACA, CCDC22 EPHX2 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.